510 related articles for article (PubMed ID: 28614209)
1. Newly Described Entities in Salivary Gland Pathology.
Skálová A; Gnepp DR; Lewis JS; Hunt JL; Bishop JA; Hellquist H; Rinaldo A; Vander Poorten V; Ferlito A
Am J Surg Pathol; 2017 Aug; 41(8):e33-e47. PubMed ID: 28614209
[TBL] [Abstract][Full Text] [Related]
2. Newly described salivary gland tumors.
Skalova A; Michal M; Simpson RH
Mod Pathol; 2017 Jan; 30(s1):S27-S43. PubMed ID: 28060365
[TBL] [Abstract][Full Text] [Related]
3. Sclerosing Polycystic "Adenosis" of Salivary Glands: A Neoplasm Characterized by PI3K Pathway Alterations More Correctly Named Sclerosing Polycystic Adenoma.
Bishop JA; Gagan J; Baumhoer D; McLean-Holden AL; Oliai BR; Couce M; Thompson LDR
Head Neck Pathol; 2020 Sep; 14(3):630-636. PubMed ID: 31605313
[TBL] [Abstract][Full Text] [Related]
4. Sclerosing Polycystic Adenoma of Salivary Glands: A Novel Neoplasm Characterized by PI3K-AKT Pathway Alterations-New Insights Into a Challenging Entity.
Skálová A; Baněčková M; Laco J; Di Palma S; Agaimy A; Ptáková N; Costes-Martineau V; Petersson BF; van den Hout MFCM; de Rezende G; Klubíčková N; Koblížek M; Koshyk O; Vaneček T; Leivo I
Am J Surg Pathol; 2022 Feb; 46(2):268-280. PubMed ID: 34510113
[TBL] [Abstract][Full Text] [Related]
5. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
6. Mammary Analogue Secretory Carcinoma.
Parekh V; Stevens TM
Arch Pathol Lab Med; 2016 Sep; 140(9):997-1001. PubMed ID: 27575269
[TBL] [Abstract][Full Text] [Related]
7. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
[TBL] [Abstract][Full Text] [Related]
8. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
Skálová A; Hyrcza MD; Leivo I
Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
[TBL] [Abstract][Full Text] [Related]
9. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
10. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E
J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
[TBL] [Abstract][Full Text] [Related]
12. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
[TBL] [Abstract][Full Text] [Related]
13. Advances in salivary gland pathology.
Cheuk W; Chan JK
Histopathology; 2007 Jul; 51(1):1-20. PubMed ID: 17539914
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland tumor "wishes" to add to the next WHO Tumor Classification: sclerosing polycystic adenosis, mammary analogue secretory carcinoma, cribriform adenocarcinoma of the tongue and other sites, and mucinous variant of myoepithelioma.
Gnepp DR
Head Neck Pathol; 2014 Mar; 8(1):42-9. PubMed ID: 24595421
[TBL] [Abstract][Full Text] [Related]
15. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
[TBL] [Abstract][Full Text] [Related]
17. Aspiration cytology of mammary analogue secretory carcinoma of the salivary gland.
Jung MJ; Kim SY; Nam SY; Roh JL; Choi SH; Lee JH; Baek JH; Cho KJ
Diagn Cytopathol; 2015 Apr; 43(4):287-93. PubMed ID: 25087572
[TBL] [Abstract][Full Text] [Related]
18. Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.
Cipriani NA; Blair EA; Finkle J; Kraninger JL; Straus CM; Villaflor VM; Ginat DT
Int J Surg Pathol; 2017 Oct; 25(7):613-618. PubMed ID: 28497708
[TBL] [Abstract][Full Text] [Related]
19. Emerging Entities in Salivary Pathology: A Practical Review of Sclerosing Microcystic Adenocarcinoma, Microsecretory Adenocarcinoma, and Secretory Myoepithelial Carcinoma.
Rooper LM
Surg Pathol Clin; 2021 Mar; 14(1):137-150. PubMed ID: 33526218
[TBL] [Abstract][Full Text] [Related]
20. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]